An Online Application to Explain Community Immunity with Personalized Avatars: A Randomized Controlled Trial (Preprint)
Hina Hakim, Julie A. Bettinger, Christine T. Chambers, S. Michelle Driedger et autres
0 citations
Anne‐Sophie Julien
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
75Publications signalées
1358Citations signalées
0Affiliations récentes
Domaines associés
Systemic Lupus Erythematosus ResearchRheumatoid Arthritis Research and TherapiesPatient-Provider Communication in HealthcareSARS-CoV-2 and COVID-19 Researchinterferon and immune responses
Publications récentes
Antimitochondrial antibodies in systemic lupus erythematosus are associated with and predict nephritis, arterial vascular events, and mortality
Yann Becker, Éric Boilard, Emmanuelle Rollet‐Labelle, Christian Lood et autres
2 citationsAnnals of the Rheumatic Diseases
P287 CALLS FOR ENGAGING PATIENT PARTNERS HAVE LARGELY GONE UNHEARD IN CARDIOVASCULAR RESEARCH
Anne‐Sophie Julien, S. Gariepy, Kelly D. Cobey, M. Albert et autres
0 citationsCanadian Journal of Cardiology
P244 PRIORITIZING HEALTH LITERACY AND PATIENT ENGAGEMENT IN PATIENT EDUCATIONAL MATERIALS
S. Soubliere, S. Gariepy, Anne‐Sophie Julien
0 citationsCanadian Journal of Cardiology
Safety of COVID-19 Boosters in People with Systemic Autoimmune Rheumatic Diseases on Rituximab (COVBIRD Study)
Nathalie Amiable, Inés Colmegna, François Harel, Anne‐Sophie Julien et autres
0 citationsThe Journal of Rheumatology
Comparing Immunogenicity with Protein Subunit and mRNA COVID-19 Vaccines in Patients with Rheumatic Diseases on Rituximab (COVBIRD Study)
Nathalie Amiable, Inés Colmegna, François Harel, Anne‐Sophie Julien et autres
0 citationsThe Journal of Rheumatology
Catalyzing research excellence and impact: Integration of cross cutters in a patient-oriented research study on engaging patients with brain-heart conditions in health decisions
Kenneth B. Lewis, Ian D. Graham, Semhal Gessese, Anne‐Sophie Julien et autres
0 citationsEuropean Journal of Cardiovascular Nursing
PROTEIN SUBUNIT AND MRNA COVID-19 VACCINES: COMPARATIVE STUDY ON INDUCED-IMMUNOGENICITY IN RITUXIMAB-TREATED PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS, RHEUMATOID ARTHRITIS AND VASCULITIS
Paul R. Fortin, Nathalie Amiable, Inés Colmegna, François Harel et autres
0 citationsThe Journal of Rheumatology
COVID-19 BOOSTER VACCINATION, EITHER MRNA OR PROTEIN SUBUNIT VACCINES, APPEARS SAFE IN RITUXIMAB-TREATED PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS, RHEUMATOID ARTHRITIS AND VASCULITIS
Paul R. Fortin, Nathalie Amiable, Inés Colmegna, François Harel et autres
0 citationsThe Journal of Rheumatology
The association between polypharmacy and disease control in rheumatoid arthritis and systemic lupus erythematosus: a cohort study
William Berthelot, Caroline Sirois, Anne‐Sophie Julien, Nathalie Amiable et autres
4 citationsRheumatology International
An Online Application to Explain Community Immunity with Personalized Avatars: A Randomized Controlled Trial
Hina Hakim, Julie A. Bettinger, Christine T. Chambers, S. Michelle Driedger et autres
2 citationsmedRxiv
Assessing the treatment response of lateral elbow tendinopathy using time-dependent ultrasonography, Doppler imaging, and elastography
David Tobaly, Patrice Tétreault, Guy Cloutier, Manon Choinière et autres
5 citationsInsights into Imaging
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.